Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Gross Margin Over TimeContracting
Percentile Rank45
3Y CAGR+0.1%
5Y CAGR-8.2%
Year-over-Year Change
Gross profit as a percentage of revenue
3Y CAGR
+0.1%/yr
vs -10.4%/yr prior
5Y CAGR
-8.2%/yr
Recent acceleration
Acceleration
+10.5pp
Accelerating
Percentile
P45
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 64.44% | -18.8% |
| 2024 | 79.36% | +26.3% |
| 2023 | 62.81% | -2.3% |
| 2022 | 64.27% | -21.5% |
| 2021 | 81.88% | -17.3% |
| 2020 | 98.95% | -1.1% |
| 2019 | 100.00% | +0.1% |
| 2018 | 99.86% | - |
| 2014 | 0.00% | -100.0% |
| 2013 | 100.00% | - |